Clinical trial

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

NCT06635057

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Tirzepatide Normalized identity: tirzepatideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-10-11

PhasePHASE4

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06635057 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.